At its inaugural meeting on February 22, the newly formed megapharmaceutical company GlaxoSmithKline (GSK; Brentford, UK) announced a restructuring of its R&D organization, creating six research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback